In nasopharyngeal carcinoma (NPC) cells, TFPI2 overexpression and a combination of cisplatin treatment were found to elicit a synergistic effect on promoting apoptosis and antitumor activity compared to cisplatin or TFPI2 treatment alone. Here, TFPI2 is linked to nasopharyngeal carcinoma.